Patents by Inventor Sheila BHEDDAH

Sheila BHEDDAH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190194319
    Abstract: Compositions comprising Achaete-scute homolog 1 (ASCL1) antibodies, and methods comprising ASCL1 antibody compositions for detecting ASCL1 expression as a diagnostic biomarker, are provided.
    Type: Application
    Filed: May 19, 2017
    Publication date: June 27, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: JEFFREY BERNSTEIN, LAURA SAUNDERS, SHEILA BHEDDAH, ENYING YOU, CASEY FRANKLIN, TIEN YIN YAU, GRAYSON KOCHI
  • Publication number: 20190022241
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: June 11, 2018
    Publication date: January 24, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: David Liu, Deepti Rokkam, Sheila Bheddah, Javier Lopez-Molina, Laura Saunders
  • Patent number: 9993566
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: August 27, 2014
    Date of Patent: June 12, 2018
    Assignee: AbbVie Stemcentrx LLC
    Inventors: David Liu, Deepti Rokkam, Sheila Bheddah, Javier Lopez-Molina, Laura Saunders
  • Publication number: 20160287720
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: August 27, 2014
    Publication date: October 6, 2016
    Applicant: Stemcentrx, Inc.
    Inventors: David LIU, Deepti ROKKAM, Sheila BHEDDAH, Javier LOPEZ-MOLINA, Laura SAUNDERS